Brand name: Valaciclovir (AN)
Valaciclovir (AN) is a medicine containing the active ingredient(s) valaciclovir. On this page you will find out more about Valaciclovir (AN), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: valaciclovir
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Valaciclovir (AN) 500 mg film-coated tablet, 10
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
For the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash.,For the treatment of ophthalmic zoster.,For the treatment of recurrent herpes labialis (cold sores),For the treatment of clinical episodes of genital herpes simplex infections.,For the prevention of recurrent genital herpes.,Reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. In addition to therapy with Valaciclovir, it is recommended that patients use safer sex practices. ,Prophylaxis of cytomegalovirus (CMV) infection and disease following solid organ transplantation in patients at risk of CMV disease.
Table of characteristics
| Active ingredient | |
|---|---|
| Visual appearance |
Blue, film-coated, capsule shaped tablets with a partial scorebar on both sides containing 'F' on one side and '9' and '3' on the other side
Images are the copyright of the Pharmacy Guild of Australia |
| Dosage Form | Tablet, film coated |
| Route of administration | Oral |
| Medicine schedule |
10: Prescription Only Medicine, or Prescription Animal Remedy
100: Prescription Only Medicine, or Prescription Animal Remedy
30: Prescription Only Medicine, or Prescription Animal Remedy
42: Prescription Only Medicine, or Prescription Animal Remedy
90: Prescription Only Medicine, or Prescription Animal Remedy
|
There is one type of pack available.
Pack type 1
| Type | Blister Pack |
|---|---|
| Storage temperature | Store below 25 degrees Celsius |
| Storage conditions | Store in a Dry Place |
| Life time | 3 Years |
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 April 2018
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Need more information?
These trusted information partners have more on this topic.
Found 29 results
Valaciclovir AN Tablets - myDr.com.au
Valaciclovir AN Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Valaciclovir RBX Tablets - myDr.com.au
Valaciclovir RBX Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Valaciclovir Pfizer Tablets - myDr.com.au
Valaciclovir Pfizer Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Valaciclovir SZ Tablets - myDr.com.au
Valaciclovir SZ Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Valaciclovir Sandoz Tablets - myDr.com.au
Valaciclovir Sandoz Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Valaciclovir Generichealth Tablets - myDr.com.au
Valaciclovir Generichealth Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Valacor Tablets - myDr.com.au
Valacor Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Herpes Simplex Virus (HSV; Cold Sores; Genital Sores; Genital Ulcers) | myVMC
There are two different strains of herpes simplex viruses: herpes simplex virus type 1 (HSV-1) and herpes simplex virus type2 (HSV-2)
Read more on myVMC – Virtual Medical Centre website
9 Things you should know about shingles
People who have had chickenpox can later develop shingles (herpes zoster), when the chickenpox virus re-activates. Shingles causes a painful rash.
Read more on myDr website
Shilova Tablets - myDr.com.au
Shilova Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 6 results
Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer | Cochrane
Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer
Read more on Cochrane (Australasian Centre) website
Antiviral drugs used as protective and preventive therapy reduce CMV disease and CMV-associated deaths in solid organ transplant recipients | Cochrane
Antiviral drugs used as protective and preventive therapy reduce CMV disease and CMV-associated deaths in solid organ transplant recipients
Read more on Cochrane (Australasian Centre) website
Antiviral agents for treatment of herpes simplex virus infection in neonates | Cochrane
The virus herpes simplex (herpes) causes a rare but devastating disease in the newborn that can range from skin and eye infection to shock, organ failure, brain infection, and death. Newborn herpes infection is an uncommon complication of active genital herpes in the mother around the time of delivery or after direct contact with a herpes blister ("fever blister", "cold sore") of an infected caregiver. We reviewed five studies conducted to assess the effects of antiviral agents (medications that reduce the spread of virus in the body) on mortality and long-term complications of herpes disease in the newborn. Antiviral agents were shown to reduce mortality from the condition, but the reduction was not statistically significant due to the small number of infants in the study. There was insufficient trial data to guide caregivers regarding the duration of antiviral therapy or dose.
Read more on Cochrane (Australasian Centre) website
Updating the management of sexually transmitted infections | Issue 6 | Volume 38 | Australian Prescriber
The control of sexually transmitted infections relies on case-finding and treatment of sexual contacts to prevent further transmission. Screening for...
Read more on Australian Prescriber website
Management of Bells palsy | Issue 3 | Volume 40 | Australian Prescriber | Australian Prescriber
Bells palsy is facial nerve paralysis of unknown cause. Left untreated, 7075% of patients make a full recovery.
Read more on Australian Prescriber website
Prescribing for patients on dialysis | Issue 1 | Volume 39 | Australian Prescriber
The pharmacokinetics of a drug may be altered in patients with renal impairment who require dialysis.
Read more on Australian Prescriber website
